Medicenna Therapeutics Balance Sheet Health
Financial Health criteria checks 6/6
Medicenna Therapeutics has a total shareholder equity of CA$18.6M and total debt of CA$0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are CA$23.3M and CA$4.6M respectively.
Key information
0%
Debt to equity ratio
CA$0
Debt
Interest coverage ratio | n/a |
Cash | CA$21.76m |
Equity | CA$18.63m |
Total liabilities | CA$4.64m |
Total assets | CA$23.27m |
Recent financial health updates
We Think Medicenna Therapeutics (TSE:MDNA) Needs To Drive Business Growth Carefully
Oct 18Medicenna Therapeutics (TSE:MDNA) Is In A Good Position To Deliver On Growth Plans
Jun 14Companies Like Medicenna Therapeutics (TSE:MDNA) Are In A Position To Invest In Growth
Feb 28Here's Why We're Not Too Worried About Medicenna Therapeutics' (TSE:MDNA) Cash Burn Situation
Nov 08Is Medicenna Therapeutics (TSE:MDNA) In A Good Position To Deliver On Growth Plans?
Mar 01Recent updates
We Think Medicenna Therapeutics (TSE:MDNA) Needs To Drive Business Growth Carefully
Oct 18Medicenna Therapeutics (TSE:MDNA) Is In A Good Position To Deliver On Growth Plans
Jun 14Companies Like Medicenna Therapeutics (TSE:MDNA) Are In A Position To Invest In Growth
Feb 28Here's Why We're Not Too Worried About Medicenna Therapeutics' (TSE:MDNA) Cash Burn Situation
Nov 08Is Medicenna Therapeutics (TSE:MDNA) In A Good Position To Deliver On Growth Plans?
Mar 01We're Hopeful That Medicenna Therapeutics (TSE:MDNA) Will Use Its Cash Wisely
Aug 07Will Medicenna Therapeutics (TSE:MDNA) Spend Its Cash Wisely?
Apr 14We're Hopeful That Medicenna Therapeutics (TSE:MDNA) Will Use Its Cash Wisely
Dec 30Financial Position Analysis
Short Term Liabilities: MDNA's short term assets (CA$23.2M) exceed its short term liabilities (CA$4.6M).
Long Term Liabilities: MDNA has no long term liabilities.
Debt to Equity History and Analysis
Debt Level: MDNA is debt free.
Reducing Debt: MDNA had no debt 5 years ago.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: MDNA has sufficient cash runway for more than a year based on its current free cash flow.
Forecast Cash Runway: MDNA has sufficient cash runway for 1.6 years if free cash flow continues to reduce at historical rates of 13% each year.